相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking
Karthik Arumugam et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2014)
Molecular docking guided structure based design of symmetrical N,N′-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors
Sree Kanth Sivan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors
Horrick Sharma et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
A combined 3D-QSAR and docking studies for the In-silico prediction of HIV-protease inhibitors
Zaheer Ul-Haq et al.
CHEMISTRY CENTRAL JOURNAL (2013)
Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach
Changdev G. Gadhe et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2013)
Exploring the Molecular Mechanism of Cross-Resistance to HIV-1 Integrase Strand Transfer Inhibitors by Molecular Dynamics Simulation and Residue Interaction Network Analysis
Weiwei Xue et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Assessing Molecular Docking Tools for Relative Biological Activity Prediction: A Case Study of Triazole HIV-1 NNRTIs
Tomasz Fraczek et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Highly Specific and Sensitive Pharmacophore Model for Identifying CXCR4 Antagonists. Comparison with Docking and Shape-Matching Virtual Screening Performance
Arnaud S. Karaboga et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Joint X-ray/Neutron Crystallographic Study of HIV-1 Protease with Clinical Inhibitor Amprenavir: Insights for Drug Design
Irene T. Weber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
The investigations on HIV-1 gp120 bound with BMS-488043 by using docking and molecular dynamics simulations
Liang Li et al.
JOURNAL OF MOLECULAR MODELING (2013)
Molecular Docking Studies of Marine Diterpenes as Inhibitors of Wild-Type and Mutants HIV-1 Reverse Transcriptase
Leonardo A. Miceli et al.
MARINE DRUGS (2013)
Complexes of HIV-1 RT, NNRTI and RNA/DNA hybrid reveal a structure compatible with RNA degradation
Mikalai Lapkouski et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Docking-based CoMFA and CoMSIA study of azaindole carboxylic acid derivatives as promising HIV-1 integrase inhibitors
S. Yu et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2013)
Identification of potential HIV-1 integrase strand transfer inhibitors: In silico virtual screening and QM/MM docking studies
K. K. Reddy et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2013)
Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex
Qiuxiang Tan et al.
SCIENCE (2013)
Synthesis, biological activity and docking study of imidazol-5-one as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
Santosh N. Mokale et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Synthesis, structure-activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors
Xiao-Dong Ma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Discovery of Inhibitors To Block Interactions of HIV-1 Integrase with Human LEDGF/p75 via Structure-Based Virtual Screening and Bioassays
Guoping Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Impact of the CXCR4 structure on docking-based virtual screening of HIV entry inhibitors
Jesus M. Planesas et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2012)
Docking, molecular dynamics and quantitative structure-activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors
Yating Mao et al.
JOURNAL OF MOLECULAR MODELING (2012)
Docking-based 3D-QSAR analyses of pyrazole derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors
Elena Cichero et al.
JOURNAL OF MOLECULAR MODELING (2012)
Identification of old drugs as potential inhibitors of HIV-1 integrase - human LEDGF/p75 interaction via molecular docking
Guoping Hu et al.
JOURNAL OF MOLECULAR MODELING (2012)
The Efficacy of Conceptual DFT Descriptors and Docking Scores on the QSAR Models of HIV Protease Inhibitors
Hemant Kumar Srivastava et al.
Medicinal Chemistry (2012)
Molecular docking of (5E)-3-(2-aminoethyl)-5-(2-thienylmethylene)-1, 3-thiazolidine-2, 4-dione on HIV-1 reverse transcriptase: novel drug acting on enzyme
Chandrabhan Seniya et al.
BIOINFORMATION (2012)
Paramagnetic Relaxation Assisted Docking of a Small Indole Compound in the HIV-1 gp41 Hydrophobic Pocket
Miriam Gochin et al.
ACS CHEMICAL BIOLOGY (2011)
Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulation
Mohsen Shahlaei et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site
David I. Rhodes et al.
CHEMBIOCHEM (2011)
3D-QSAR and Docking Studies on the HEPT Derivatives of HIV-1 Reverse Transcriptase
Ramaswamy Sree Latha et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
Combined Approach Using Ligand Efficiency, Cross-Docking, and Antitarget Hits for Wild-Type and Drug-Resistant Y181C HIV-1 Reverse Transcriptase
Alfonso T. Garcia-Sosa et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Computationally-Guided Optimization of a Docking Hit to Yield Catechol Diethers as Potent Anti-HIV Agents
Mariela Bollini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Binding modes of diketo-acid inhibitors of HIV-1 integrase: A comparative molecular dynamics simulation study
Meilan Huang et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2011)
Docking study of HIV-1 reverse transcriptase with phytochemicals
Abhik Seal et al.
BIOINFORMATION (2011)
An insight into the opening path to semi-open conformation of HIV-1 protease by molecular dynamics simulation
Lu Tao et al.
AIDS (2010)
Maraviroc A Review of its Use in the Management of CCR5-Tropic HIV-1 Infection
Caroline M. Perry
DRUGS (2010)
Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African populations
Anabela C. P. Picton et al.
INFECTION GENETICS AND EVOLUTION (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection
Raymond Yost et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors
C. Teixeira et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Vicriviroc: a CCR5 antagonist for treatment-experienced patients with HIV-1 infection
Tim Kuemmerle et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Comparative Docking Study of Anibamine as the First Natural Product CCR5 Antagonist in CCR5 Homology Models
Guo Li et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Stable Docking of Neutralizing Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Monoclonal Antibodies 2F5 and 4E10 Is Dependent on the Membrane Immersion Depth of Their Epitope Regions
S. Moses Dennison et al.
JOURNAL OF VIROLOGY (2009)
A Novel Co-Crystal Structure Affords the Design of Gain-of-Function Lentiviral Integrase Mutants in the Presence of Modified PSIP1/LEDGF/p75
Stephen Hare et al.
PLOS PATHOGENS (2009)
Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking
Violeta I. Perez-Nueno et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Insights into the interactions between HIV-1 integrase and human LEDGF/p75 by molecular dynamics simulation and free energy calculation
Yaxue Zhao et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Raltegravir (MK-0518): An integrase inhibitor for the treatment of HIV-1
Teresa Hope Evering et al.
DRUGS OF TODAY (2007)
Biophysical evidence of two docking sites of the carboxyl heptad repeat region within the amino heptad repeat region of gp41 of human immunodeficiency virus type 1
Ding-Kwo Chang et al.
ANTIVIRAL RESEARCH (2007)
In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate
Andrea Savarino
RETROVIROLOGY (2007)
Prediction of HIV-1 entry inhibitors neomycin-arginine conjugates interaction with the CD4-gp120 binding site by molecular modeling and multistep docking procedure
Alexander Berchanski et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Targeting HIV-1 through molecular modeling and docking studies of CXCR4: Leads for therapeutic development
Shailza Singh et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
HIV coreceptor CXCR4 antagonists
Dominique Schols
CURRENT OPINION IN HIV AND AIDS (2006)
Cutting edge:: Human β defensin 3 -: A novel antagonist of the HIV-1 coreceptor CXCR4
Zhimin Feng et al.
JOURNAL OF IMMUNOLOGY (2006)
Modeling the structural basis of human CCR5 chemokine receptor function: From homology model building and molecular dynamics validation to agonist and antagonist docking
A. Fano et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Prediction of the binding mode between BMS-378806 and HIV-1 gp120 by docking and molecular dynamics simulation
Ren Kong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2006)
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
P Cherepanov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase
M Llano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase
P Cherepanov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Nuclear import of the pre-integration complex (PIC): The Achilles heel of HIV ?
SC Piller et al.
CURRENT DRUG TARGETS (2003)
The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression level
K Princen et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
Molecular docking and 3D-QSAR studies on gag peptide analogue inhibitors interacting with human cyclophilin A
M Cui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
MIP-1α, MIP-1β, RANTES, and ATAC/lymphotactin function together with IFN-γ as type 1 cytokines
BG Dorner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding
JCH Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II
NM Zhou et al.
BIOCHEMISTRY (2000)
分享论文
